QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · IEX Real-Time Price · USD
34.69
+1.49 (4.49%)
At close: Jul 19, 2024, 4:00 PM
34.70
+0.01 (0.03%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
QuidelOrtho Revenue
QuidelOrtho had revenue of $2.86B in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $711.00M. In the year 2023, QuidelOrtho had annual revenue of $3.00B.
Revenue (ttm)
$2.86B
Revenue Growth
-7.95%
P/S Ratio
0.81
Revenue / Employee
$403,197
Employees
7,100
Market Cap
2.32B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
Dec 31, 2021 | 1.70B | 36.90M | 2.22% |
Dec 31, 2020 | 1.66B | 1.13B | 210.66% |
Dec 31, 2019 | 534.89M | 12.61M | 2.41% |
Dec 31, 2018 | 522.29M | 244.54M | 88.05% |
Dec 31, 2017 | 277.74M | 86.14M | 44.96% |
Dec 31, 2016 | 191.60M | -4.53M | -2.31% |
Dec 31, 2015 | 196.13M | 11.97M | 6.50% |
Dec 31, 2014 | 184.16M | 6.83M | 3.85% |
Dec 31, 2013 | 177.33M | 21.58M | 13.86% |
Dec 31, 2012 | 155.74M | -2.86M | -1.80% |
Dec 31, 2011 | 158.60M | 45.26M | 39.94% |
Dec 31, 2010 | 113.34M | -50.94M | -31.01% |
Dec 31, 2009 | 164.28M | 36.15M | 28.21% |
Dec 31, 2008 | 128.13M | 10.07M | 8.53% |
Dec 31, 2007 | 118.07M | 12.05M | 11.37% |
Dec 31, 2006 | 106.02M | 13.72M | 14.86% |
Dec 31, 2005 | 92.30M | 13.61M | 17.29% |
Dec 31, 2004 | 78.69M | -13.77M | -14.89% |
Dec 31, 2003 | 92.46M | 19.19M | 26.19% |
Dec 31, 2002 | 73.27M | 2.29M | 3.23% |
Dec 31, 2001 | 70.98M | 5.49M | 8.37% |
Dec 31, 2000 | 65.50M | 8.98M | 15.88% |
Dec 31, 1999 | 56.52M | 7.04M | 14.23% |
Mar 31, 1998 | 49.48M | 4.76M | 10.64% |
Mar 31, 1997 | 44.72M | 9.67M | 27.58% |
Mar 31, 1996 | 35.05M | 3.52M | 11.15% |
Mar 31, 1995 | 31.54M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortrea Holdings | 3.01B |
Amneal Pharmaceuticals | 2.50B |
Evolent Health | 2.18B |
Privia Health Group | 1.69B |
Myriad Genetics | 774.20M |
UFP Technologies | 407.33M |
Intellia Therapeutics | 52.60M |
Janux Therapeutics | 7.29M |
QDEL News
- 5 days ago - QuidelOrtho to Report Second Quarter 2024 Financial Results - Business Wire
- 27 days ago - QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 5 weeks ago - The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact - Accesswire
- 5 weeks ago - QuidelOrtho Corporation Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm - Business Wire
- 5 weeks ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho - GlobeNewsWire
- 5 weeks ago - The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL) - Business Wire
- 5 weeks ago - DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm - Business Wire